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Reactive oxygen species (ROS) have been implicated in the pathogenesis of numerous disease processes. Epithelial cells lining the respiratory air-
ways are uniquely vulnerable regarding potential for oxidative damage due to their potential for exposure to both endogenous (e.g., mitochondrial
respiration, phagocytic respiratory burst, cellular oxidases) and exogenous (e.g., air pollutants, xenobiotics, catalase negative organisms) oxidants.
Airway epithelial cells use several nonenzymatic and enzymatic antioxidant mechanisms to protect against oxidative insult. Nonenzymatic defenses
include certain vitamins and low molecular weight compounds such as thiols. The enzymes superoxide dismutase, catalase, and glutatione peroxi-
dase are major sources of antioxidant protection. Other materials associated with airway epithelium such as mucus, epithelial lining fluid, and even
the basement membrane/extracellular matrix may have protective actions as well. When the normal balance between oxidants and antioxidants is
upset, oxidant stress ensues and subsequent epithelial cell alterations or damage may be a critical component in the pathogenesis of several respira-
tory diseases. Oxidant stress may profoundly alter lung physiology including pulmonary function (e.g., forced expiratory volumes, flow rates, and
maximal inspiratory capacity), mucociliary activity, and airway reactivity. ROS may induce airway inflammation; the inflammatory process may serve
as an additional source of ROS in airways and provoke the pathophysiologic responses described. On a more fundamental level, cellular mecha-
nisms in the pathogenesis of ROS may involve activation of intracellular signaling enzymes including phospholipases and protein kinases stimulating
the release of inflammatory lipids and cytokines. Respiratory epithelium may be intimately involved in defense against, and pathophysiologic
changes invoked by, ROS. -Environ Health Perspect 102(Suppl 10):85-90 (1994)
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Introduction
Reactive oxygen species (ROS) including
free radicals (e.g., hydroxyl radical [OH],
superoxide anion [°-]) and nonradicals
(e.g., hydrogen peroxide [H202], hypo-
chlorite [HOC)]) have been implicated in
the pathogenesis of diseases ranging from
cataracts to cancer. ROS may damage tis-
sues through peroxidation of cell lipids,
DNA strand breakage, alteration of amino
acids in either structural or functional pro-
teins, or alterations of cellular metabolism.
Epithelial cells lining the respiratory airways
are in a uniquely vulnerable position
regarding potential for oxidative damage. In
addition to potential oxidant exposure from
normal aerobic cellular metabolism, these
cells are exposed to relatively high oxygen
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tensions and are often exposed to air pollu-
tants, phagocytic cells, catalase negative
bacteria, and reactive xenobiotic-drug
metabolites. Not unexpectedly, ROS have
been specifically implicated in the patho-
genesis of a variety of respiratory diseases
including adult respiratory distress syn-
drome (ARDS), asthma, emphysema, and
asbestosis (1,2).
The respiratory tract is exposed to ROS
from a wide variety ofsources, both exoge-
nous and endogenous. Inhaled pollutants
such as ozone (03), nitrogen dioxide, auto-
mobile exhaust, and cigarette smoke con-
tain numerous oxidants (3). Aerobic
bacteria produce ROS; those which are
catalase negative (e.g., Mycoplasma pneu-
moniae) can be an additional source of
exogenous H202 in infected airways (4).
Phagocytic cells, a first line of defense
against microorganisms, produce superox-
ide anions and related products (H202,
HOCI, OH*)(5). While these ROS are
necessary for defense of the host, they sec-
ondarily expose host tissues to damage as
well (1). Superoxide anion also is formed
nonenzymatically in epithelial cells, as in
all aerobic cells, through autooxidations of
mitochondrial electron transport chain
constituents (6). Peroxisomes and other
organelles contain many cellular oxidases
that produce ROS (e.g., xanthine oxidase,
galactose oxidase, indoleamine dioxyge-
nase, etc.) (7). Hyperoxia provokes
increased endogenous production ofsuper-
oxide and H202 in lung cells (8,9); 100%
O2increases oxygen tension in the lung to
approximately 700 mm Hg, while oxygen
tension in other tissues changes minimally
(1). Finally, several xenobiotics are believed
to damage lungs through production of
oxygen free radicals as the compounds are
metabolized (i.e., paraquat, bleomycin,
nitrofurantoin) (10-12).
Since proteins, lipids, carbohydrates,
and DNA are susceptible to oxidation,
there are a number ofmechanisms whereby
ROS can harm cells and tissues. Cells are
subject to damage through oxidation of
structural or functional proteins, such as
elastin, collagen, and polysaccharides (1).
Enzymes like a-I protease inhibitor may
be altered, profoundly affecting function of
the cell (13). Certain membrane functions
may be disturbed also; oxidation of mem-
brane sulfhydryl groups alters a variety of
functions such as K+ pumping capacity or
amino acid transport ability (14). H202
decreases Na+,K+-ATPase activity indepen-
dent of H202-induced ATP depletion
(15). Membrane receptors (e.g., P-adreno-
ceptors) are functionally damaged after
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exposure of airway tissue to ROS in vitro
(16). Oxidants also may injure cells by
causing peroxidation of cellular lipids.
Lipid peroxidation involves initial abstrac-
tion ofa hydrogen from a polyunsaturated
fatty acid by a potent oxidant, leaving a
carbon with a single unpaired electron.
The lipid radical then reacts with oxygen to
form lipid peroxyl radicals (also strong oxi-
dants) that then extract a second hydrogen
from another methylene carbon. This reac-
tion continues in a chainwise manner con-
verting carbons of membrane
phospholipids to hydroperoxides (17).
This type ofreaction would certainly dam-
age cell membranes and also produce reac-
tion products like aldehydes, which are
themselves toxic to cells (6). H202 can be
especially harmful as it can rapidly perme-
ate cells and inhibit ATP synthesis through
glycolytic and oxidative phosphorylation
pathways (18). Oxidants also harm cells
through damage to DNA (19). Oxidants
may induce base hydroxylation and strand
breaks that lead to cell death or malignant
transformation (18). ROS can also exacer-
bate inflammation. They can produce
potent chemoattractants to recruit
inflammatory cells that in turn produce
more ROS (20). ROS also increase local
production of inflammatory eicosanoids
(21). These effects can lead to epithelial
cell shedding and loss (13,22,23).
Respiratory tract tissues are more vul-
nerable to the deleterious effects ofROS
than are many other tissues. The respira-
tory system is designed for gas exchange;
air flows from the nasal passages to the
large conducting airways, then to the
smaller airways, and finally into alveoli
where the actual exchange takes place.
All of these surfaces are lined by epithe-
lial cells. Respiratory epithelial cells are
exposed to high oxygen tensions, and
they are the first cells to contact inhaled
oxidants. The epithelial cells also are
exposed to ROS generated by inflamma-
tory reactions, xenobiotic metabolism,
and endogenous production. For these
reasons epithelial cells may be a first line
ofdefense for the respiratory tract in pro-
tection from oxidants. When the normal
balance between oxidants and antioxi-
dants is upset, oxidant stress ensues and
subsequent epithelial damage may be a
crucial component in the pathogenesis of
several respiratory diseases.
Antioxidative Protection by
Airway Epithelium
As exposure to potentially damaging ROS
is unavoidable for aerobic organisms, a
complex set of antioxidant defenses have
developed. Cells contain many antioxi-
dants, some of which are nonenzymatic
radical scavengers, others that prevent radi-
cal formation, and others that enzymati-
cally transform ROS. The most important
antioxidant enzymes are superoxide dismu-
tase (SOD), catalase (CAT), and glu-
tathione cycle enzymes such as glutathione
peroxidase (GPO). SOD catalyzes the dis-
mutation of superoxide anion to oxygen
and hydrogen peroxide (H202); this same
reaction also occurs spontaneously, but the
rate is greatly increased by SOD. The latter
two enzyme systems are used in cell defense
against the common oxidant, H202'
Catalase actually converts H202 to water
and oxygen. The glutathione cycle lets
H202 (or organic hydroperoxides) react
with reduced glutathione in the presence of
glutathione peroxidase to form water (or an
alcohol) and glutathione disulfide.
NonenzymaticAntioxidant Defenses
Respiratory epithelium may use several
antioxidant strategies. Nonenzymatic
epithelial antioxidants include both small
and large molecular weight compounds.
The low molecular weight antioxidants
include vitamins E and C, 5-carotene, uric
acid, thiols, and taurine (24). Vitamin E is
a lipophilic chain-breaking antioxidant; it
acts by stopping the chain reaction involved
in lipid peroxidation (17). Carotenoids and
vitamin C are more hydrophilic and may
quench radicals in the nonlipid cellular
compartments (17) [vitamin C can also act
as a prooxidant (2)]. The hydrophilic mol-
ecule urate has both chain-breaking and
preventive (by stabilizing vitamin C)
antioxidant activity (17). Thiols and tau-
rine are largely hydrophilic chain-breaking
antioxidants, protecting critical sulfhydryl
groups on proteins (17). Larger molecular
weight antioxidants include lactoferrin,
albumin, ceruloplasmin, and transferrin
(25). Several of these compounds act by
binding heavy metals, making them
unavailable for production of free radicals
(i.e., participation in the Fenton reaction
to produce hydroxyl radical) or participa-
tion in lipid peroxidation.
EnzymaticAntioxidantDefenses
Tracheal, bronchial, and alveolar epithe-
lium possess enzymatic antioxidants. These
cells are capable of rapidly scavenging
exogenous H202. In both tracheal and
alveolar epithelial cells, CAT seems quanti-
tatively the more important of the H202
scavenging enzymes at concentrations of
Ho°2 > 10 M [(26-28); LA Cohn et al.,
submitted]. Inhibition ofCAT significantly
inhibits the ability of tracheal and alveolar
epithelial cells to consume H202, while
inhibition ofGPO does not. This does not
mean that GPO is not an important
epithelial protector: inhibition of GPO
does potentiate the damage inflicted on
epithelial cells by exogenous H202
(26,28-30). Epithelial cells also possess
two forms of SOD. The Cu,Zn form of
SOD is the more potent ofthe two and is
primarily cytosolic and nuclear in location;
this form is constitutive in expression (31).
The manganese form ofSOD is located in
the mitochondria and is inducible in
expression (31). There is evidence that
mitochondrial Mn-SOD can be up-regu-
lated by ROS or cytokines such as TNF,
interleukin 1 (IL-1), and IL-6 (32-36).
The ability to increase levels ofthis cellular
antioxidant may protect epithelium in situ-
ations where inflammation and subsequent
increases in ROS are likely (37). Increases
in Mn-SOD would more likely be protec-
tive in situations where endogenous ROS
pose more of a threat than exogenous
ROS, such as hyperoxia (38,39).
EpiAxelium-assocatedAntioxidts
Materials closely associated with airway
epithelial cells may contribute to antioxi-
dant defense. Epithelial lining fluid (ELF)
is a thin layer oflocally secreted substances
and plasma ultrafiltrate that bathe the
epithelial surface. This fluid has marked
antioxidant protective effects, mostly due
to CAT, released by the normal turnover of
airway epithelium (40). Other antioxidants
in ELF include SOD, GPO, GSH, vitamin
C, vitamin E, transferrin, and ceruloplas-
min (40-42). Airway submucosal gland
secretions also contain antioxidants; in
human secretions uric acid is especially
important (43). Mucus also is known to
have antioxidant capabilities (44). The
sugar moieties in mucus may act similarly
to mannitol and glucose in scavenging
hydroxyl radical and H202 (45,46).
Mucus glycoproteins react with H202; in
the process both H202 and glycoproteins
are degraded (44,47,48). In our studies
with guinea pig primary tracheal epithelial
cells (GPTE), removal ofthe apical mucus
layer reduced the efficiency of H202 scav-
enging (LA Cohn et al., submitted). The
extracellular matrix of the airway epithe-
lium also may contribute to epithelial
antioxidant protection. Matrix material
remaining on collagen-coated filters after
GPTE cells were removed retained a
marked ability to scavenge exogenous H202
(LA Cohn et al., submitted). Extracellular
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antioxidant enzymes could be contained
within the ECM. For example, Coursin et
al. used immunostaining to show dense
deposits of GPO in lung connective tissue
(49), and lung extracellular matrix con-
tains SOD as well (50). H202 could also
be degraded through interactions with low
molecular weight molecules like GSH
which may be localized to the ECM, or it
could be consumed by nonspecific interac-
tions with matrix molecules such as gly-
cosaminoglycans, laminin, heparin sulfate
proteoglycan, etc.
Functional Responses
ofAirway Epithelium to
Oxidant Stress
This section describes the effects ofoxidant
stress (a shift in the prooxidant/antioxidant
balance toward oxidation) on airway
epithelial cells. ROS have been shown to
elicit effects on the lung by decreasing
overall pulmonary function. Respiratory
airway inflammation incited by oxidant
stress may promote the pathogenesis of
pulmonary dysfunction. Second messenger
products and feedback pathways may
mechanistically link ROS to the observed
functional responses at molecular and cel-
lular levels.
PulmonaryFunction
Oxidant stress, especially due to oxidant air
pollutants, has been observed to pro-
foundly affect pulmonary physiology.
Many of these pathophysiologic effects
may be mediated by products released
from airway epithelial cells either by patho-
physiologic stimuli or by cell damage. 03
induces transient changes in human lung
function, including decreased forced expi-
ratory volumes and flow rates (51), stimu-
lation of the tracheobronchial mucociliary
system (52), increased nonspecific airway
reactivity, increased specific airway resis-
tance, increased respiratory frequency on
exercise, and an involuntary reduction of
maximal inspiratory capacity (53). It
should be noted that 03 decreases mucocil-
iary transport in sheep (54) and other
species in contrast to the human data men-
tioned above. Hazucha and associates (53)
explain the measured responses and
increases in airway reactivity to broncho-
constrictor challenge by 03 stimulating,
and maybe sensitizing, airway sensory
fibers.
Hypersecretion of respiratory mucus is
associated with the pathogenesis of several
airway diseases including asthma, acute
and chronic bronchitis, and cystic fibrosis
(55). Oxidant stress can increase secretion
of respiratory mucin and depress ciliary
beating efficiency, diminishing the ability
of the mucociliary system to clear poten-
tially pathogenic agents. 03 and sulfur
dioxide provoke mucus hypersecretion in
the respiratory airways (55). Studies in our
laboratory have shown that enzymatically
generated oxidants (purine/xanthine oxi-
dase [P/XO]) provoke hypersecretion of
respiratory mucins in GPTE cells [(56);
CM Li, unpublished observation]. Ciliated
epithelial cell necrosis has been observed
after 03 exposure in rats (57). Sulfur diox-
ide causes airway hyperreactivity (58) and
has been reported to damage ciliated air-
way epithelial cells and decrease mucocil-
iary transport in dogs (59). Nitrogen
dioxide decreases mucociliary transport
and functional residual capacity in dogs
(60). H202 reversibly inhibits airway cil-
iary activity (61).
Pulmonary dysfunction associated with
exposure to ROS may involve direct effects
on airway epithelial cells causing release of
mediators, or may result from damage to
these cells. Epithelial-derived mediators
may act through autocrine or paracrine
pathways to affect neighboring cells and
tissues, i.e., mediators may produce the
mechanical responses by acting on airway
smooth muscle or nerve endings. Damage
to, or destruction of, ciliated epithelial cells
would obviously decrease mucociliary
clearance function.
AirwayInflammation
A complex sequence of events is involved
in the inflammatory process, each step of
which can have detrimental effects on the
lung and its host defense functions (62).
Although pulmonary function changes are
transient, there is strong evidence that air-
way inflammation has a more prolonged
time course. Airway inflammation, assessed
by several parameters (including inflamma-
tory lipid mediators and cytokines), has
been well documented in studies of bron-
choalveolar lavage fluid (BALF) ofhumans
and animals exposed to 03. Human BALF
(obtained by several different 03 exposure
protocols) exhibits increases in number of
neutrophils, eicosanoid production
[prostaglandin E2 (PGE2), PGF2a, and
thromboxane B2 (TxB2)], indices ofairway
permeability (protein, albumin, and
immunoglobulin G), fibrogenic process
activation (tissue factor, Factor VII, uroki-
nase plasminogen activator, and
fibronectin), the cytokine IL-6, and the
complement component C3a (62,63). 03
induces transient increases in the expres-
sion of IL-6 and IL-8 mRNAs and
increases release of fibronectin, IL-6, and
IL-8 in virally transformed human
bronchial epithelial (BEAS-2B) cells in
vitro (64). Mineral dust particles such as
quartz, asbestos, and silica induce pul-
monary inflammation and activate immune
cells to produce ROS. Some mineral dusts
even contain endogenous radicals (65).
Airway inflammation resulting from
diverse stimuli provokes hypersecretion of
mucus (55). P/XO stimulates mucus hyper-
secretion by a mechanism involving
cyclooxygenase metabolism of arachidonic
acid (AA) to PGF2a (56). Decreased epithe-
lial barrier function causes edema that may
contribute to hypersecretion of mucus by
exposing airway secretory cells to plasma
secretagogues (55). Increased epithelial cell
paracellular permeability (decreased barrier
function) has been reported in a) pul-
monary epithelium of dogs exposed to sul-
fur dioxide (59) and nitrogen dioxide (60);
b) Madin Darby canine kidney (MDCK)
epithelial cells exposed to H202,
glucose/glucose oxidase, and xanthine/XO
(66); c) ferret tracheal epithelium exposed
to xanthine/XO (67); and d) rat alveolar
epithelium exposed to H202 (15). P/XO
also induces permeability edema in isolated
perfused rabbitlungs (68).
Airway inflammation can be induced by
exposure to ROS or alternatively ROS can
be produced by resident (epithelial cells and
macrophages) or nonresident (neutrophils)
pulmonary cells during inflammatory
events. Inflammatory processes in the air-
ways may incite some or all ofthe changes
in pulmonary function discussed in the pre-
vious section.
SecondMessengerPathways
On a more fundamental level, the mecha-
nism(s) of oxidant toxicity may involve
activation ofsecond messenger pathways in
pulmonary target cells. Exposure ofairway
epithelial cells to oxidant stress can affect
synthesis and release of lipid mediators,
such as eicosanoids and platelet activating
factor (PAF), by a mechanism involving
activation ofcellular phospholipases: phos-
pholipase A2 (PLA2), phospholipase C
(PLC), and phospholipase D (PLD).
Eicosanoids and PAF are bioactive sub-
stances with potent proinflammatory
actions. They may activate other cells by
binding to cell surface receptors and induc-
ing second messenger formation (69). t-
Butyl hydroperoxide (t-BOOH) activates
PLA2, without requiring new protein syn-
thesis, and stimulates cyclooxygenase
metabolism of the released AA in bovine
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pulmonary endothelial cells (70). AA and
eicosanoids are released by BEAS-2B cells
after in vitro 03 exposure (71,72). 03
exposure also has been shown to increase
release of PAF by several different pul-
monary cell types (72). H202 liberates sat-
urated and unsaturated fatty acids, activates
PLA2 and PLC, and impairs incorporation
of unesterified fatty acids into complex
lipids (ATP-dependent reacylation) in
bovine pulmonary endothelial cells (73). t-
BOOH regulates the activity of cyclooxy-
genase and lipoxygenases in rabbit platelets:
low concentrations enhance formation of
TxB2 and hydroxyheptadecatrienoic acid
(HHT), while relatively higher concentra-
tions inhibit their formation (74).
PLC-mediated second messenger path-
ways regulate a large variety of cellular
processes including metabolism, secretion,
contraction, neural activity, and cell prolifer-
ation (75) and may also mediate chemotaxis
and other aspects of inflammation. ROS
generated by P/XO increase the synthesis of
Gacq/,' a GTP-binding ("G") protein con-
nected with phosphoinositide-specific PLC
(PLCfJ) signaling (H Li, unpublished obser-
vation). H202 increases intracellular cal-
cium, and activates PLA2 and PLC in rat
alveolar epithelial cells (76). 03 activates
PLA2, PLC, and PLD and increases release
of PAF by GPTE cells (DT Wright et al.,
submitted) and P/XO activates PLA2 and
PLC [(56); DT Wright, unpublished obser-
vation].
Protein kinase C (PKC) plays a critical
role in many aspects of cell metabolism,
activation, and proliferation (77). PAF
stimulates mucus secretion through a
lipoxygenase-dependent pathway in GPTE
cells (78) and a PKC-zeta-mediated path-
way in feline tracheal epithelial cells (79).
GPTE cells exposed to PAF (or phorbol
esters) release H202 through a mechanism
involving activation of PKC (80). P/XO
stimulates PKC translocation and activation
in GPTE and BEAS-2B cells (B Fischer,
unpublished observations). PKC can be acti-
vated by ROS (produced upon UVB radia-
tion) without prior activation of PLC or
PLA2 in human platelets (81). H202 has
been shown to reversibly inhibit ciliary
activity in sheep airways by a mechanism
involving activation of second messenger
pathways including PKC (61). H202
increases epithelial permeability in MDCK
cells via a mechanism that involves activa-
tion ofPLC and consequendy PKC (82,83)
It has been well documented that sev-
eral cell types possess PLD activity that can
be stimulated by various inflammatory
mediators (84-86). H202 and linoleic
acid hydroperoxide activate PLD, indepen-
dent ofPKC activity, in bovine pulmonary
endothelial cells (87).
ROS may exert their effects on airway
epithelial cells by a mechanism involving
either direct oxidation of phospholipases
(perhaps even associated cell surface recep-
tor proteins or G proteins), or peroxidative
changes in membrane lipids surrounding
these signal transducing elements.
Phospholipases, especially the acyl hydro-
lase phospholipase A2 and the phosphodi-
esterases PLC and PLD, are ubiquitous
membrane lipid-hydrolyzing enzymes that
are critical elements of stimulus-response
coupling. Alterations in membrane phos-
pholipid metabolism may be central to oxi-
dant-mediated cell injury as the liberation
of AA and eicosanoids has been observed
frequently and lysophospholipids act as
biological detergents which are lytic to
membranes (88). Second messengers gen-
erated by these phospholipase pathways in
response to oxidant stress may act through
autocrine or paracrine mechanisms to
evoke numerous cellular alterations includ-
ing inflammation (increased epithelial per-
meability, eicosanoid and PAF release, and
infiltration of inflammatory cells) and
functional responses such as increased
secretion ofmucus.
Conclusions
Airway epithelial cells are in a uniquely vul-
nerable position regarding exposure to
ROS from both endogenous and exoge-
nous sources. They are equipped with a
complex array of nonenzymatic and enzy-
matic antioxidant defenses to combat these
constant oxidative insults. When the deli-
cate balance between oxidant burden and
antioxidant defense is overwhelmed, oxi-
dant stress ensues. Effects of this oxidant
stress on airway epithelium are diverse.
Significantly, second messenger systems
appear to be activated, relating to increased
airway inflammation and possibly leading
to numerous pulmonary function impair-
ments. Oxidant stress therefore may be
important in the pathogenesis ofnumerous
respiratory diseases.
Mechanistically, oxidant stress may con-
tribute to initiation and/or propagation of
lung disease. Pulmonary injury may be
mediated by sustained hyperoxia (1), oxi-
dant air pollutants (gaseous and particu-
late) (7), and certain xenobiotic toxins
(e.g., paraquat) (7). Other pulmonary dis-
eases whose pathology is strongly associated
with ROS (but that are not necessarily ini-
tiated by ROS) include ARDS (89),
emphysema (1), and idiopathic pulmonary
fibrosis (24). ROS also may propagate the
overall respiratory disease process in condi-
tions such as asthma (13), cystic fibrosis
(24), and human immunodeficiency virus
infection (90).
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